Press Room

Washington, D.C. July 14, 2012. Today, the New York Times released a groundbreaking story on the government’s secret spying program on a group of whistleblowers employed by the Food and Drug Administration (FDA). Stephen M. Kohn, the Executive Director of the National Whistleblower Center and the lead attorney for the FDA whistleblowers, issued the following statement: We hope that […]

Washington DC. July 12, 2012. Senator Charles E. Grassley (R-Iowa) has announced his objection to the Senate’s consideration of two nominees for Assistant Secretary positions at the Treasury Department. The announcement came yesterday after the Treasury Department failed to respond to the Senator’s inquiry about the IRS Whistleblower Program holding up to Congressional intent and […]

Washington, D.C. July 11, 2012. The Washington Post reported today that the United States Department of Justice (DOJ) and the Federal Bureau of Investigation (FBI) have launched the largest post-conviction case review in American history. The review was sparked by the work of Dr. Frederic Whitehurst, a top FBI crime lab expert who initially blew the whistle on […]

Washington, D.C. July 11, 2012. The National Whistleblower Center (NWC) has filed an amicus curiae (“friend of the court”) brief in a precedent-setting whistleblower tax case pending before the U.S. Tax Court. The case, Insinga v. Commissioner of Internal Revenue, alleged that the IRS delay in ruling on whistleblower reward cases was tantamount to a denial of claims. […]

Washington, D.C. July 2, 2012. Today, GlaxoSmithKline agreed to settle four whistleblower lawsuits and to pay $3 billion for committing healthcare fraud. Whistleblowers reported that the company had engaged in off-label marketing for multiple drugs and had failed to report important safety data. The agreement marks the largest healthcare fraud settlement in American history. The […]